Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2022studies shown
Showing 1,651-1,675 of 2,022
CompletedNCT04432688

The Safety and Effectiveness of Latuda® Post-marketing Surveillance in the Treatment of Chinese Schizophrenia Patients

This study exists to learn from real-world information that can show how a therapy or guided support program fits into care. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted.

SchizophreniaOther
Countries
China
Sponsor
Sumitomo Pharma (Suzhou) Co., Ltd.
Condition
Schizophrenia
CompletedNCT04532034

Facilitating Engagement in Evidence-Based Treatment for Early Psychosis

This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 30 Years
Countries
United States
Sponsor
Temple University
Condition
Schizophrenia
CompletedNCT05742893

Comparison of a Speech-Language Assessment Tool for Pragmatic and Discourse Skills in Schizophrenia Spectrum Disorders

This study exists to see whether questionnaires and follow-up reports can make care clearer and more responsive. Researchers are trying to understand whether questionnaires and follow-up reports can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 99 Years
Countries
France
Sponsor
Centre Hospitalier Universitaire de Nice
Condition
Schizophrenia
TerminatedNCT01764568

Contrasting Group Therapy Methods for Psychosis

This study exists to compare options and see whether a guided support group offers something meaningfully different. Researchers are trying to understand whether a guided support group can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 19 Years to 60 Years
Countries
Canada
Sponsor
University of British Columbia
Condition
Schizophrenia
CompletedNCT06356389

A Clinical Trial to Evaluate Safety, Tolerance and Pharmacokinetics of JX11502MA Capsule in Patients With Schizophrenia.

This study exists to compare options and see whether blood tests and biological markers offers something meaningfully different. Researchers are trying to understand whether blood tests and biological markers can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
China
Sponsor
Zhejiang Jingxin Pharmaceutical Co., Ltd.
Condition
Schizophrenia
RecruitingNCT06351514

An Open-Label, Single Arm Study of the Efficacy of Accelerated Intermittent Theta Burst Stimulation in Schizophrenia Patients With Persistent Negative Symptoms

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 21 Years to 65 Years
Countries
Singapore
Sponsor
Institute of Mental Health, Singapore
Condition
Schizophrenia
CompletedNCT05345977

eMotiph: E-mental Health Solution for Patients With Schizophrenia

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can make support easier to access outside standard clinic visits.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
Spain
Sponsor
Grupo Pulso
Condition
Schizophrenia
CompletedNCT02155699

Exercise and Markers of Medial Temporal Health in Youth At-risk for Psychosis

This study exists to see whether this type of care is workable and worth testing more broadly. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 16 Years to 24 Years
Countries
United States
Sponsor
University of Colorado, Boulder
Condition
Schizophrenia
CompletedNCT03983421

Feasibility of an Early Detection Program for Early Psychosis on a College Campus

This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can better prevent setbacks and support longer-term stability.

SchizophreniaOtherFrom 15 Years to 30 Years
Countries
United States
Sponsor
University of New Mexico
Condition
Schizophrenia
TerminatedNCT03463902

Transcranial Direct Current Stimulation (tDCS) to Improve Gesture Control

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Switzerland
Sponsor
University of Bern
Condition
Schizophrenia
CompletedNCT03648268

Using Transcranial Magnetic Stimulation (TMS) to Understand 'Negative' Symptoms of Schizophrenia

This study exists to explore whether brain scans or other body measurements could improve care and understanding. Researchers are trying to understand whether brain scans or other body measurements can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Beth Israel Deaconess Medical Center
Condition
Schizophrenia
CompletedNCT02670291

Treatment of Auditory Hallucinations in Schizophrenia With Bilateral Theta Burst Stimulation

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can better prevent setbacks and support longer-term stability.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Germany
Sponsor
University Hospital Tuebingen
Condition
Schizophrenia
CompletedNCT06326840

Clinical Efficacy and Adverse Reactions of Antipsychotic Treatment

This study exists to see whether blood tests and biological markers can make care clearer and more responsive. Researchers are trying to understand whether blood tests and biological markers can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
Taiwan
Sponsor
Taipei Medical University Hospital
Condition
Schizophrenia
CompletedNCT03955250

Mobile After-Care Support App: Pilot RCT

This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherOver 18 Years
Countries
United States
Sponsor
Butler Hospital
Condition
Schizophrenia
CompletedNCT02946255

Testing the Effectiveness of The Welcome Basket Intervention

This study exists to see whether a guided support group is workable and worth testing more broadly. Researchers are trying to understand whether a guided support group can better prevent setbacks and support longer-term stability.

SchizophreniaOtherOver 18 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia
TerminatedNCT04825860

A Clinical Trial to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic People With Schizophrenia, Followed by an Open-label Extension Phase

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
China, Japan, Philippines, Taiwan
Sponsor
Sumitomo Pharma Co., Ltd.
Condition
Schizophrenia
CompletedNCT05716802

Dance/Movement Therapy for Bone Mineral Density in Schizophrenia

This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 40 Years to 60 Years
Countries
China
Sponsor
Hebei Province Veterans Hospital
Condition
Schizophrenia
CompletedNCT03093064

Inflammatory Response In Schizophrenia

This study exists to learn from real-world information that can show how brain scans or other body measurements fits into care. Researchers are trying to understand what brain scans or other body measurements can reveal about signals in the brain or body that may guide care later on.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
United Kingdom
Sponsor
King's College London
Condition
Schizophrenia
CompletedNCT04022577

Effects of Adherence Therapy on Medication Adherence in Patients With Schizophrenia Spectrum Disorder

This study exists to understand what helps a therapy or guided support program work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether a therapy or guided support program can give earlier or clearer feedback during care.

SchizophreniaOtherFrom 20 Years to 64 Years
Countries
Taiwan
Sponsor
National Yang Ming Chiao Tung University
Condition
Schizophrenia
Not Yet RecruitingNCT06042712

Belief-updating, Speech and Psychosis

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherFrom 18 Years to 40 Years
Countries
Global
Sponsor
King's College London
Condition
Schizophrenia